Team:Waterloo
From 2014.igem.org
Super.suzie (Talk | contribs) |
Super.suzie (Talk | contribs) |
||
Line 12: | Line 12: | ||
<td style="border:1px solid black;" colspan="3" align="center" height="150px" bgColor=#FF404B> | <td style="border:1px solid black;" colspan="3" align="center" height="150px" bgColor=#FF404B> | ||
<h1 >WELCOME TO iGEM 2014! </h1> | <h1 >WELCOME TO iGEM 2014! </h1> | ||
- | + | <b>2014 Project Description:<b> | |
Waterloo’s 2014 iGEM project aims to remove antibiotic resistance in MRSA populations by using CRISPR and RNA interference systems that target mecA expression. The gene mecA in MRSA is responsible for it’s resistance against beta-lactam antibiotics. CRISPRi and RNAi systems can be incorporated onto a Staphylococcus conjugative plasmid, which would be able to replicate and transfer within a MRSA population, effectively disabling the antibiotic resistant phenotype in the population over time. A beta-lactam antibiotic can then be administered to kill the newly antibiotic-sensitive bacteria. | Waterloo’s 2014 iGEM project aims to remove antibiotic resistance in MRSA populations by using CRISPR and RNA interference systems that target mecA expression. The gene mecA in MRSA is responsible for it’s resistance against beta-lactam antibiotics. CRISPRi and RNAi systems can be incorporated onto a Staphylococcus conjugative plasmid, which would be able to replicate and transfer within a MRSA population, effectively disabling the antibiotic resistant phenotype in the population over time. A beta-lactam antibiotic can then be administered to kill the newly antibiotic-sensitive bacteria. |
Revision as of 19:16, 15 August 2014
WELCOME TO iGEM 2014!2014 Project Description: Waterloo’s 2014 iGEM project aims to remove antibiotic resistance in MRSA populations by using CRISPR and RNA interference systems that target mecA expression. The gene mecA in MRSA is responsible for it’s resistance against beta-lactam antibiotics. CRISPRi and RNAi systems can be incorporated onto a Staphylococcus conjugative plasmid, which would be able to replicate and transfer within a MRSA population, effectively disabling the antibiotic resistant phenotype in the population over time. A beta-lactam antibiotic can then be administered to kill the newly antibiotic-sensitive bacteria. To execute this idea, the project was divided into three milestones. The first milestone aims to model the ability of CRISPRi and RNAi to inhibit gene expression in the level one organism, Staphylococcus epidermidis. The second milestone aims to develop an effective conjugative plasmid in Staphylococcus to ensure a proper delivery mechanism for CRISPRi and/or RNAi. Measuring the effectiveness of the conjugative plasmid will allow us to apply our current mathematical models to determine the optimal time periods to apply the antibiotics to the population after the addition of the donor cells. The third milestone would be to evaluate and improve this system for MRSA populations.Your team has been approved and you are ready to start the iGEM season!
|
||||||||||||
| ||||||||||||
Requirements | ||||||||||||
Please be sure to keep these links, your audience will want to find your: |
There are a few wiki requirements teams must follow:
Visit the Wiki How To page for a complete list of requirements, tips and other useful information. |
|||||||||||
Tips | ||||||||||||
We are currently working on providing teams with some easy to use design templates.
For a full wiki list, you can visit iGEM 2013 web sites and iGEM 2012 web sites lists. |
This wiki will be your team’s first interaction with the rest of the world, so here are a few tips to help you get started:
|